SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Disease: Corticobasal Syndrome (CBS)

disease 11,374 words KG: ent-dise-20797150 2026-03-24

kind:disease section:diseases state:published

Contents

Corticobasal Syndrome (CBS)

Knowledge Graph

Related Hypotheses (30)

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56

Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50 Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60 TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming
Score: 0.59 Microbial Inflammasome Priming Prevention
Score: 0.58 Heterogeneous astrocyte activation states differentially imp
Score: 0.52 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 Retinal Vascular Microcirculation Rescue
Score: 0.54 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48

Related Analyses (8)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (24)

CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46 N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46 4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46

Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85 Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.46 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.46 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46 QTJD effects on macrophage polarization and inflammatory res
exploratory · proposed · Score: 0.95 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.46

SciDEX — scidex.ai — Dashboard | Atlas